Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
West Pharmaceutical Services Inc
NYSE:WST
West Pharmaceutical Services Inc
NYSE:WST
Price:
413.835
USD
1.46%
Market Closed
Market Cap:
$28.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
West Pharmaceutical Services Inc
NYSE:WST
|
US |
|
F
|
Foremost Clean Energy Ltd
CNSX:FAT
|
CA |
Wall St Price Targets
WST Price Forecast
Based on 18 analysts
Based on 18 analysts
+18% Upside
from
$413.835
today
West Pharmaceutical Services Inc (WST)’s 12-month stock price forecast through November 2027 has a consensus target of $489.6, implying 18% upside. The forecast is based on price targets from 18 Wall Street analysts.
WST Analyst Rating
Based on 16 analysts
Based on 16 analysts
Analysts rate WST Strong buy, with 15 of 16 recommending Buy or Strong buy.
West Pharmaceutical Services Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is WST's stock price target?
Price Target
489.6
USD
489.6
USD
According to Wall Street analysts, the average 1-year price target for WST is 489.6 USD with a low forecast of 340.37 USD and a high forecast of 525 USD.
What is the Revenue forecast for West Pharmaceutical Services Inc?
Projected CAGR
9%
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 5 years is 9%.
What is the Gross Profit forecast for West Pharmaceutical Services Inc?
Projected CAGR
11%
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 5 years is 11%.
What is the Operating Income forecast for West Pharmaceutical Services Inc?
Projected CAGR
13%
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 5 years is 13%.
What is the Pre-Tax Income forecast for West Pharmaceutical Services Inc?
Projected CAGR
19%
19%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 14%. The projected CAGR for the next 3 years is 19%.
What is the Net Income forecast for West Pharmaceutical Services Inc?
Projected CAGR
12%
12%
Over the last 13 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 5 years is 12%.
